X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (38) 38
humans (36) 36
female (30) 30
male (30) 30
aged (26) 26
middle aged (24) 24
pneumonia (20) 20
mortality (16) 16
aged, 80 and over (15) 15
analysis (12) 12
community-acquired pneumonia (12) 12
respiratory system (12) 12
adult (11) 11
patients (10) 10
treatment outcome (10) 10
adults (9) 9
bacterial pneumonia (9) 9
epidemiology (9) 9
prospective studies (9) 9
risk factors (9) 9
antibiotics (8) 8
health aspects (8) 8
hospitalization (8) 8
prognosis (8) 8
research (8) 8
anesthesiology (7) 7
clinical trials (7) 7
guidelines (7) 7
infectious diseases (7) 7
netherlands (7) 7
outcome assessment (7) 7
population (7) 7
risk (7) 7
surgery (7) 7
anesthesiology and pain medicine (6) 6
anti-bacterial agents - therapeutic use (6) 6
community-acquired infections - epidemiology (6) 6
human (6) 6
netherlands - epidemiology (6) 6
odds ratio (6) 6
pharmacology & pharmacy (6) 6
pharmacy (6) 6
retrospective studies (6) 6
sepsis (6) 6
therapy (6) 6
acute kidney injury (5) 5
biomarkers - blood (5) 5
cardiac & cardiovascular systems (5) 5
cardiology and cardiovascular medicine (5) 5
cohort studies (5) 5
community-acquired infections - mortality (5) 5
diagnosis (5) 5
infections (5) 5
management (5) 5
medical research (5) 5
oncology (5) 5
outcomes (5) 5
pneumonia - drug therapy (5) 5
pneumonia - epidemiology (5) 5
pneumonia - mortality (5) 5
public health (5) 5
pulmonary and respiratory medicine (5) 5
adolescent (4) 4
biomarkers (4) 4
biomedische technologie en medicijnen (4) 4
c-reactive protein (4) 4
care and treatment (4) 4
community-acquired infections - blood (4) 4
community-acquired infections - drug therapy (4) 4
community-acquired infections - microbiology (4) 4
data bases (4) 4
disease (4) 4
drug dosages (4) 4
drug therapy (4) 4
farmacie (4) 4
hospital mortality (4) 4
lung cancer (4) 4
medicine, experimental (4) 4
obesity (4) 4
peripheral vascular disease (4) 4
pneumonia - blood (4) 4
procalcitonin (4) 4
public, environmental & occupational health (4) 4
severity (4) 4
statistical analysis (4) 4
studies (4) 4
validation (4) 4
ziekenhuisstructuur en organisatie van de gezondheidszorg (4) 4
abridged index medicus (3) 3
article (3) 3
atypical pathogens (3) 3
automated compounding (3) 3
bevacizumab (3) 3
cancer therapies (3) 3
cardiac patients (3) 3
children (3) 3
community-acquired infections - diagnosis (3) 3
coronary artery bypass grafting (3) 3
dexamethasone (3) 3
diabetes (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 7, pp. 819 - 827
Journal Article
Annals of Surgery, ISSN 0003-4932, 08/2016, Volume 263, Issue 6, pp. 1207 - 1212
Objective: To assess the association of systemic inflammation and outcome after major abdominal surgery. Background: Major abdominal surgery carries a high... 
anastomosis dehiscence | postoperative complication | C-reactive protein | abdominal surgery | major clinical study | heart infarction | Major abdominal surgery | postoperative period | NCT02150486 | Interleukin-6 | scoring system | blood sampling | interleukin 6 | atrial fibrillation | Systemic inflammatory response syndrome | tumor necrosis factor alpha | pneumonia | congestive heart failure | priority journal | C reactive protein | female | human | Postoperative complications | clinical trial | elective surgery | Mortality | aged | treatment outcome | article | sensitivity and specificity | early diagnosis | predictive value | wound infection | length of stay | reoperation | respiratory failure | male | sepsis | COLORECTAL SURGERY | SURGERY | DEXAMETHASONE | RESECTION | RISK | RANDOMIZED CONTROLLED-TRIAL | SEPSIS | interleukin-6 | systemic inflammatory response syndrome | MORBIDITY | major abdominal surgery | mortality | postoperative complications | AORTIC-VALVE IMPLANTATION | SYSTEMIC INFLAMMATORY RESPONSE | Prospective Studies | Humans | Risk Factors | Tumor Necrosis Factor-alpha - blood | Male | Biomarkers - blood | Postoperative Complications - mortality | Abdomen - surgery | Postoperative Complications - diagnosis | C-Reactive Protein - metabolism | Elective Surgical Procedures - mortality | Interleukin-6 - blood | Female | Aged | Early Diagnosis | Systemic Inflammatory Response Syndrome - diagnosis | Systemic Inflammatory Response Syndrome - mortality
Journal Article
European Journal of Epidemiology, ISSN 0393-2990, 1/2014, Volume 29, Issue 10, pp. 767 - 775
The heterogeneity in case-control studies on the associations between community-acquired pneumonia (CAP) and ACE-inhibitors (ACEi), statins, and proton pump... 
PHARMACO-EPIDEMIOLOGY | Case control studies | Prescription drugs | Pneumonia | Databases | Primary health care | Hospital administration | General practice | Proton pump inhibitors | Medications | Drug prescriptions | risk assessment | comparative study | Community acquired pneumonia | major clinical study | proton pump inhibitor | Epidemiology | Epidemiology methods | hydroxymethylglutaryl coenzyme A reductase inhibitor | prevalence | Case–control | drug exposure | female | hospital patient | human | Statins | reference database | middle aged | article | dipeptidyl carboxypeptidase inhibitor | controlled study | prescription | clinical protocol | adult | Ace-inhibitors | male | Public Health | Medicine & Public Health | Infectious Diseases | Oncology | Cardiology | Case-control | MORTALITY | PROJECT | METAANALYSIS | BIAS | VALIDATION | ENZYME INSERTION/DELETION POLYMORPHISM | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | THERAPY | DRUGS | COHORT | COMMUNITY-ACQUIRED-PNEUMONIA | Community-Acquired Infections - etiology | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Netherlands - epidemiology | Pneumonia - prevention & control | Male | Case-Control Studies | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Aged, 80 and over | Adult | Female | Odds Ratio | Proton Pump Inhibitors - adverse effects | Pneumonia - etiology | Risk Assessment | Pneumonia - epidemiology | Risk Factors | Logistic Models | Treatment Outcome | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Adolescent | Aged | Community-Acquired Infections - prevention & control | Population Surveillance | Bacterial pneumonia | Pharmacy | Risk factors | ACE inhibitors | Antacids
Journal Article
Journal Article
BMC Infectious Diseases [E], ISSN 1471-2334, 06/2016, Volume 16, Issue 1, p. 299
Journal Article
Journal Article
The European respiratory journal, ISSN 0903-1936, 12/2018, Volume 52, Issue 6
The divergence between clinical trial results and real-world outcomes is largely unknown for many cancer types. The present study aims overall to assess the... 
PHASE-III TRIAL | 1ST-LINE TREATMENT | PERFORMANCE STATUS | MULTICENTER TRIAL | CISPLATIN VS. GEMCITABINE | STAGE IIIB | MAINTENANCE BEVACIZUMAB | RESPIRATORY SYSTEM | OPEN-LABEL | GEMCITABINE PLUS CARBOPLATIN | COOPERATIVE-ONCOLOGY-GROUP
Journal Article
Breast Cancer: Basic and Clinical Research, ISSN 1178-2234, 1/2019, Volume 13, p. 1178223418823238
Objective: The aim of this study was to assess the real-world effectiveness and tolerability of palbociclib combined with endocrine therapy for the treatment... 
real-world | clinical practice | efficacy-effectiveness gap | palbociclib | metastatic breast cancer | tolerability
Journal Article
Journal Article
Clinical Chemistry and Laboratory Medicine (CCLM), ISSN 1434-6621, 03/2019, Volume 57, Issue 4, pp. 442 - 451
Journal Article